Strokes in paroxysmal atrial fibrillation have more favorable outcome than in permanent atrial fibrillation

Acta Neurologica Scandinavica

Volumn 119, Issue 5, 2009, Pages 325-331

  Staszewski, Jacek ^a   Brodacki, B ^a   Tomczykiewicz, K ^a   Kotowicz, J ^a   Stepien, A ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Ischemic stroke; Non cardioembolic stroke; Paroxysmal atrial fibrillation; Permanent atrial fibrillation; Stroke outcome

Indexed keywords

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; RISK FACTOR; STROKE;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BRAIN INFARCTION; CHRONIC DISEASE; COHORT STUDIES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); POLAND; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 64549084576     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2008.01100.x     Document Type: Article

References (32)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk for stroke: the Framingham Study. Stroke 1991 22 : 983 8.
2. Hohnloser SH, Pajitnev D, Pogue J et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy. J Am Coll Cardiol 2007 50 : 2156 61.
3. Li-Saw-Hee FL, Blann AD, Gurney D, Lip GY. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation: effects of cardioversion and return of left atrial function. Eur Heart J 2001 22 : 1741 7.
4. Lip GY, Hee FL. Paroxysmal atrial fibrillation. QJM 2001 94 : 665 78.
5. Levy S, Camm AJ, Saksena S et al. International consensus on nomenclature and classification of atrial fibrillation: a collaborative project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol 2003 14 : 443 5.
6. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation. J Am Med Assoc 2001 285 : 2864 70.
7. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991 337 : 1521 6.
8. Miller VT, Rothrock JF, Pearce LA, Feinberg WM, Hart RG, Anderson DC. Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Neurology 1993 43 : 32 6.
9. Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika 1965 52 : 591 611.
10. Hollander M, Wolfe DA. The two-sample location problem. In : Hollander M, Wolfe DA, eds. Nonparametric statistical methods. Practical nonparametric statistics, 3rd edn. New York : Wiley & Sons, 1973 67 82.
11. Cisternino MD, Giaquinto S, Maiolo I, Palma E, Vittoria V. On the outcome in stroke patients one year later: the role of atrial fibrillation. Eur J Neurol 2003 10 : 67 70.
12. Marini C, De Santis F, Sacco S et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke Results from a population-based study. Stroke 2005 36 : 1115 9.
13. Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. Stroke 1999 30 : 1223 9.
14. Lammie GA, Brannan J, Wardlaw JM. Incomplete lacunar infarction (type Ib lacunes). Acta Neuropathol 1998 96 : 163 71.
15. Jung DK, Devuyst G, Maeder P, Bogusslavsky J. Atrial fibrillation with small subcortical infarcts. J Neurol Neuropsychiatry 2001 70 : 344 9.
16. Hylek EM, Go AS, Chang Y et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003 349 : 1019 26.
17. Berg JM, Gerritsen WBM, Haas FJLM et al. Pretreatment with oral anticoagulants decreases platelet activation in patients before and after percutaneus coronary intervention. Thromb Haemost 2002 88 : 924 30.
18. Nozawa T, Inoue H, Iwasa A et al. Effects of anticoagulation intensity on hemostatic markers in patients with nonvalvular atrial fibrillation. Circ J 2004 68 : 29 34.
19. Yip H-K, Liou C-W, Chang H-W, Lan M-Y, Liu J-S, Chen M-C. Link between platelet activity and outcomes after an ischemic stroke. Cerebrovasc Dis 2005 20 : 120 8.
20. Turaj W, Słowik A, Dziedzic T et al. Increased plasma fibrinogen predicts one-year mortality in patients with acute ischemic stroke. J Neurol Sci 2006 246 : 13 9.
21. Fisher CM. Reducing risks of cerebral embolism. Geriatrics 1979 34 : 59 61.
22. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-density, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in atrial Fibrillation III. Randomised clinical trial. Lancet 1996 348 : 633 8.
23. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria. Stroke 2001 32 : 2735 40.
24. Gustafsson C, Blomback M, Britton M, Hamsten A, Svensson J. Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. Stroke 1990 21 : 47 51.
25. Lip GYH, Lip PL, Zarifis J et al. Fibrin d-dimer and β- thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Circulation 1996 94 : 425 31.
26. Sohara H, Amitani S, Kurose M, Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 1997 29 : 106 12.
27. Lip GYH, Lowe GDO, Rumley A, Dunn FG. Plasma fibrinogen and fibrin d-dimer levels in paroxysmal atrial fibrillation: Evidence of intermediate levels of intravascular thrombogenesis. Am Heart J 1996 131 : 724 30.
28. Petersen PJ, Kastrup J, Videbaek R. Cerebral blood flow before and after cardioversion of atrial fibrillation. Cereb Blood Flow Metab 1989 9 : 422 5.
29. Castillo J, Leira R, García MM, Serena J, Blanco M, Dávalos A. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke 2004 35 : 520 6.
30. Lip GY, Blann AD, Farooqi IS, Zarifis J, Sagar G, Beevers DG. Sequential alterations in haemorheology, endothelial dysfunction, platelet activation and thrombogenesis in relation to prognosis following acute stroke: The West Birmingham Stroke Project. Blood Coagul Fibrinolysis 2002 13 : 339 47.
31. Appelros P, Nydevik I, Seiger A, Terént A. Predictors of severe stroke: Influence of preexisting dementia and cardiac disorders. Stroke 2002 33 : 2357 62.
32. Liao J, Khalid Z, Scallan C et al. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: A systematic review. Stroke 2007 38 : 2935 40.